by Thea Cecilie Engelsen,University of OsloCredit: Unsplash/CC0 Public DomainAntibiotic shortages disrupt patient care, increase treatment costs, reduce effectiveness, and contribute to the rise
by Thea Cecilie Engelsen,University of OsloCredit: Unsplash/CC0 Public DomainAntibiotic shortages disrupt patient care, increase treatment costs, reduce effectiveness, and contribute to the rise
byTexas Biomedical Research InstituteParticles generated from the attenuated Lassa virus (rLASV/IGR-CD, right) look very similar to wild-type Lassa virus (rLASV-WT, left) but do not have the abi
byTexas Biomedical Research InstituteParticles generated from the attenuated Lassa virus (rLASV/IGR-CD, right) look very similar to wild-type Lassa virus (rLASV-WT, left) but do not have the abi
Promising therapeutic approach for metabolic liver diseases—researchers target enzyme related to fat metabolismbyMedical University of ViennaAtglistatin improves streptozotocin and HFD-induced M
Promising therapeutic approach for metabolic liver diseases—researchers target enzyme related to fat metabolismbyMedical University of ViennaAtglistatin improves streptozotocin and HFD-induced M
International study reveals COVID-19 pandemic's impact on other causes of deathbyUniversity of OxfordCredit: Pixabay/CC0 Public DomainResearchers have analyzed cause-of-death data for 24 cou
International study reveals COVID-19 pandemic's impact on other causes of deathbyUniversity of OxfordCredit: Pixabay/CC0 Public DomainResearchers have analyzed cause-of-death data for 24 cou
by Béatrice St-Cyr-Leroux,University of MontrealCredit: Unsplash/CC0 Public DomainCystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosi
by Béatrice St-Cyr-Leroux,University of MontrealCredit: Unsplash/CC0 Public DomainCystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosi